CLINIQUE
ĪĪ¹Ī± ĻĪ±ĻĪ±Ī³Ī³ĪµĪ»ĪÆĪµĻ ĻĪæĻ ĻĻĪ±Ī³Ī¼Ī±ĻĪæĻĪæĪ¹ĪæĻĪ½ĻĪ±Ī¹ ĪĻĻ ĻĪ¹Ļ 12:00 Ī¹ĻĻĻĪæĻ Ī½ ĪæĪ¹ ĻĪ±ĻĪ±ĪŗĪ¬ĻĻ ĻĻĻĪ½ĪæĪ¹ ĻĪ±ĻĪ¬Ī“ĪæĻĪ·Ļ:
Clinique Superdefense™ SPF 25 Fatigue + 1st Signs Of Age Multi-Correcting Cream for Oilier Skin
PG-1595
AĻĻ
47,40€
ĪĪ³ĻĻĪ±ĻĪµ ĻĻĻĪ±. Ī Ī»Ī®ĻĻĻĪµ ĻĪµ 3 Ī“ĻĻĪµĪ¹Ļ Ī¼Īµ
- Περιγραφή
- Αποστολή
- Επιστροφή
"ĪĻ
ĻĪ½Ī¬" Ī¬Ī¼ĪµĻĪ± ĪŗĪ±Ī¹ ĻĻ
Ī½ĪµĻĻĪ¼ĪµĪ½Ī±, ĻĪ±ĻĪÆĪ¶ĪµĪ¹ 12 ĻĻĪµĻ ĻĻĻĪµĪ¹Ī½ĻĻĪ·ĻĪ± ĪµĪ½Ī¬Ī½ĻĪ¹Ī± ĻĻĪ·Ī½ ĪŗĪæĻĻĪ±ĻĪ· Ī³Ī¹Ī± ĻĪ¹Īæ Ī½ĪµĪ±Ī½Ī¹ĪŗĪ® ĻĻĪ· ĻĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī±. ĪĪæĪ·ĪøĪ¬ ĪæĻĪ±ĻĪ¬ ĻĻĪ·Ī½ ĪµĻĪ±Ī½ĻĻĪøĻĻĪ· ĻĻĻĻĻĪ½ ĻĪ·Ī¼Ī±Ī“Ī¹ĻĪ½ Ī³Ī®ĻĪ±Ī½ĻĪ·Ļ, Ī±Ī½ĪæĪ¼ĪæĪ¹ĻĪ¼ĪæĻĻĪ·Ļ Ļ
ĻĪ®Ļ, ĪøĪ±Ī¼ĻĪ®Ļ ĻĻĪ·Ļ, Ī»ĪµĻĻĻĪ½ Ī³ĻĪ±Ī¼Ī¼ĻĪ½ ĪŗĪ±Ī¹ ĻĻ
ĻĪÆĪ“ĻĪ½. ĪĪæĪ·ĪøĪ¬ ĻĻĪ·Ī½ Ī¬Ī¼Ļ
Ī½Ī± ĪµĪ½Ī¬Ī½ĻĪ¹Ī± ĻĪµ ĪĪ½Ī± ĻĪ»Ī®ĪøĪæĻ ĻĻĪ³ĻĻĪæĪ½ĻĪ½ ĪµĻĪ¹ĪøĪµĻĪ¹ĪŗĻĪ½ ĻĪ±ĻĪ±Ī³ĻĪ½ĻĻĪ½. ĪĪ½ĪøĪµĪŗĻĪ¹ĪŗĻ ĻĪµ Ī¹Ī“ĻĻĻĪ± ĪŗĪ±Ī¹ Ļ
Ī³ĻĪ±ĻĪÆĪ±. ĪĪ· Ī»Ī¹ĻĪ±ĻĪ® ĻĻĪ½ĪøĪµĻĪ·.
ĪĪ±ĻĪ¹ĪŗĪ¬ Ī£Ļ ĻĻĪ±ĻĪ¹ĪŗĪ¬/ Ī¤ĪµĻĪ½ĪæĪ»ĪæĪ³ĪÆĪ±
ā¢ Ī¤ĪµĻĪ½ĪæĪ»ĪæĪ³ĪÆĪ± Stop Signsā¢ ĪµĪ½Ī¬Ī½ĻĪ¹Ī± ĻĻĪæĻ Ļ ĻĻĪ³ĻĻĪæĪ½ĪæĻ Ļ ĪµĻĪ¹ĪøĪµĻĪ¹ĪŗĪæĻĻ ĻĪ±ĻĪ¬Ī³ĪæĪ½ĻĪµĻ ĻĪæĻ ĻĻĪæĪŗĪ±Ī»ĪæĻĪ½ ĪŗĪæĻĻĪ±ĻĪ· ĻĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī± ĪŗĪ±Ī¹ ĪµĻĪ¹ĻĪ±ĻĻĪ½ĪæĻ Ī½ ĻĪ· Ī³Ī®ĻĪ±Ī½ĻĪ·. Ī ĻĪæĻĻĪ±ĻĪµĻĪµĪ¹ ĪµĪ½Ī¬Ī½ĻĪ¹Ī± ĻĻĪ·Ī½ Ī±ĪŗĻĪ¹Ī½ĪæĪ²ĪæĪ»ĪÆĪ± UVA/B, ĻĻĻĪ±Ī½ĻĪ· ĪŗĪ±Ī¹ Ī¬Ī»Ī»ĪæĻ Ļ ĪµĻĪµĪøĪ¹ĻĻĪ¹ĪŗĪæĻĻ Ī³Ī¹Ī± ĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī± ĻĪ±ĻĪ¬Ī³ĪæĪ½ĻĪµĻ. Ī Ī±ĻĪĻĪµĪ¹ Ī±Ī½ĻĪ¹ĪæĪ¾ĪµĪ¹Ī“ĻĻĪ¹ĪŗĪ® ĻĻĪæĻĻĪ±ĻĪÆĪ± ĻĪ»Ī· ĻĪ·Ī½ Ī·Ī¼ĪĻĪ±.
ā¢ ĪĪ½ĻĪ·Ī»Ī¹Ī±ĪŗĪ¬ ĻĪÆĻĻĪ± ĻĻĻĻ Abovenzone ĪŗĪ±Ī¹ Octisalate ĻĻĪæĻĻĪ±ĻĪµĻĪæĻ Ī½ ĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī± Ī±ĻĻ ĻĪ¹Ļ Ī±ĪŗĻĪÆĪ½ĪµĻ UVA & UVB.
ā¢ ĪĪ½ĻĪ¹ĪæĪ¾ĪµĪ¹Ī“ĻĻĪ¹ĪŗĪ¬ ĻĻĻĻ Ī· ĪĪ¹ĻĪ±Ī¼ĪÆĪ½Ī· C, Ī· ĪĪ¹ĻĪ±Ī¼ĪÆĪ½Ī· Ī ĪŗĪ±Ī¹ Ī· ĪĻĪ³ĪæĪøĪµĪ¹ĪæĪ½ĪÆĪ½Ī· ĻĻĪæĻĻĪ±ĻĪµĻĪæĻ Ī½ ĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī± Ī±ĻĻ ĻĪøĪæĻĪĻ ĻĪæĻ ĪæĻĪµĪÆĪ»ĪæĪ½ĻĪ±Ī¹ ĻĻĪ¹Ļ ĪµĪ»ĪµĻĪøĪµĻĪµĻ ĻĪÆĪ¶ĪµĻ.
ā¢ Ī ĪµĻĪ¹ĪĻĪµĪ¹ ĪĪŗĻĻĪ»Ī¹ĻĪ¼Ī± Ī¦Ī»ĪæĪ¹ĪæĻ ĪĪŗĪ±ĪŗĪÆĪ±Ļ (Alibizia Julibrissin), ĪĪ±ĻĪµĪĪ½Ī· ĪŗĪ±Ī¹ ĪĪ½Ī± ĻĻĪ¼ĻĪ»ĪæĪŗĪæ ĪµĪ½ĪĻĪ³ĪµĪ¹Ī±Ļ ĻĪæĻ ĻĪµĻĪ¹Ī»Ī±Ī¼Ī²Ī¬Ī½ĪµĪ¹ ĪĻĪµĪ±ĻĪÆĪ½Ī· ĪŗĪ±Ī¹ ĪĪ±ĻĪ½Ī¹ĻĪÆĪ½Ī·.
ĪĪ±ĻĪ¹ĪŗĪ¬ Ī£Ļ ĻĻĪ±ĻĪ¹ĪŗĪ¬/ Ī¤ĪµĻĪ½ĪæĪ»ĪæĪ³ĪÆĪ±
ā¢ Ī¤ĪµĻĪ½ĪæĪ»ĪæĪ³ĪÆĪ± Stop Signsā¢ ĪµĪ½Ī¬Ī½ĻĪ¹Ī± ĻĻĪæĻ Ļ ĻĻĪ³ĻĻĪæĪ½ĪæĻ Ļ ĪµĻĪ¹ĪøĪµĻĪ¹ĪŗĪæĻĻ ĻĪ±ĻĪ¬Ī³ĪæĪ½ĻĪµĻ ĻĪæĻ ĻĻĪæĪŗĪ±Ī»ĪæĻĪ½ ĪŗĪæĻĻĪ±ĻĪ· ĻĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī± ĪŗĪ±Ī¹ ĪµĻĪ¹ĻĪ±ĻĻĪ½ĪæĻ Ī½ ĻĪ· Ī³Ī®ĻĪ±Ī½ĻĪ·. Ī ĻĪæĻĻĪ±ĻĪµĻĪµĪ¹ ĪµĪ½Ī¬Ī½ĻĪ¹Ī± ĻĻĪ·Ī½ Ī±ĪŗĻĪ¹Ī½ĪæĪ²ĪæĪ»ĪÆĪ± UVA/B, ĻĻĻĪ±Ī½ĻĪ· ĪŗĪ±Ī¹ Ī¬Ī»Ī»ĪæĻ Ļ ĪµĻĪµĪøĪ¹ĻĻĪ¹ĪŗĪæĻĻ Ī³Ī¹Ī± ĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī± ĻĪ±ĻĪ¬Ī³ĪæĪ½ĻĪµĻ. Ī Ī±ĻĪĻĪµĪ¹ Ī±Ī½ĻĪ¹ĪæĪ¾ĪµĪ¹Ī“ĻĻĪ¹ĪŗĪ® ĻĻĪæĻĻĪ±ĻĪÆĪ± ĻĪ»Ī· ĻĪ·Ī½ Ī·Ī¼ĪĻĪ±.
ā¢ ĪĪ½ĻĪ·Ī»Ī¹Ī±ĪŗĪ¬ ĻĪÆĻĻĪ± ĻĻĻĻ Abovenzone ĪŗĪ±Ī¹ Octisalate ĻĻĪæĻĻĪ±ĻĪµĻĪæĻ Ī½ ĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī± Ī±ĻĻ ĻĪ¹Ļ Ī±ĪŗĻĪÆĪ½ĪµĻ UVA & UVB.
ā¢ ĪĪ½ĻĪ¹ĪæĪ¾ĪµĪ¹Ī“ĻĻĪ¹ĪŗĪ¬ ĻĻĻĻ Ī· ĪĪ¹ĻĪ±Ī¼ĪÆĪ½Ī· C, Ī· ĪĪ¹ĻĪ±Ī¼ĪÆĪ½Ī· Ī ĪŗĪ±Ī¹ Ī· ĪĻĪ³ĪæĪøĪµĪ¹ĪæĪ½ĪÆĪ½Ī· ĻĻĪæĻĻĪ±ĻĪµĻĪæĻ Ī½ ĻĪ·Ī½ ĪµĻĪ¹Ī“ĪµĻĪ¼ĪÆĪ“Ī± Ī±ĻĻ ĻĪøĪæĻĪĻ ĻĪæĻ ĪæĻĪµĪÆĪ»ĪæĪ½ĻĪ±Ī¹ ĻĻĪ¹Ļ ĪµĪ»ĪµĻĪøĪµĻĪµĻ ĻĪÆĪ¶ĪµĻ.
ā¢ Ī ĪµĻĪ¹ĪĻĪµĪ¹ ĪĪŗĻĻĪ»Ī¹ĻĪ¼Ī± Ī¦Ī»ĪæĪ¹ĪæĻ ĪĪŗĪ±ĪŗĪÆĪ±Ļ (Alibizia Julibrissin), ĪĪ±ĻĪµĪĪ½Ī· ĪŗĪ±Ī¹ ĪĪ½Ī± ĻĻĪ¼ĻĪ»ĪæĪŗĪæ ĪµĪ½ĪĻĪ³ĪµĪ¹Ī±Ļ ĻĪæĻ ĻĪµĻĪ¹Ī»Ī±Ī¼Ī²Ī¬Ī½ĪµĪ¹ ĪĻĪµĪ±ĻĪÆĪ½Ī· ĪŗĪ±Ī¹ ĪĪ±ĻĪ½Ī¹ĻĪÆĪ½Ī·.
Ī£Ī·Ī¼Ī±Ī½ĻĪ¹ĪŗĻ: Ī£Īµ ĻĪµĻĪÆĪæĪ“Īæ ĪµĪŗĻĻĻĻĪµĻĪ½ & ĻĻĪæĻĻĪæĻĻĪ½ ĪµĪ½Ī“ĪĻĪµĻĪ±Ī¹ Īæ ĻĻĻĪ½ĪæĻ ĻĪ±ĻĪ¬Ī“ĪæĻĪ·Ļ Ī½Ī± Ī±Ļ
Ī¾Ī·ĪøĪµĪÆ Ī»ĻĪ³Ļ Ī¼ĪµĪ³Ī¬Ī»ĪæĻ
ĻĪ³ĪŗĪæĻ
ĻĪ±ĻĪ±Ī³Ī³ĪµĪ»Ī¹ĻĪ½.
Ī Ī±ĻĪ±Ī³Ī³ĪµĪ»ĪÆĪµĻ Ī¼Īµ ĻĻĪæĻĻĪ½ĻĪ± Ī¼Īµ ĻĪ· ĻĪ®Ī¼Ī±Ī½ĻĪ· OUTLET ĪµĪŗĻĪµĪ»ĪæĻĪ½ĻĪ±Ī¹ Ī¼Īµ 2 ĪµĻĪ³Ī¬ĻĪ¹Ī¼ĪµĻ Ī·Ī¼ĪĻĪµĻ ĪŗĪ±ĪøĻ
ĻĻĪĻĪ·ĻĪ·.
ĪĻĻĻĪæĻ ĪĻĪæĻĻĪæĪ»Ī®Ļ:
ĪĪ©Ī”ĪĪĪ Ī³Ī¹Ī± ĻĪ±ĻĪ±Ī³Ī³ĪµĪ»ĪÆĪµĻ Ī¬Ī½Ļ ĻĻĪ½ 70ā¬
2,5ā¬ Ī³Ī¹Ī± ĻĪ±ĻĪ±Ī³Ī³ĪµĪ»ĪÆĪµĻ ĪĻĻĀ 70ā¬
ĪĪ¹Ī± ĻĪ±ĻĪ±Ī³Ī³ĪµĪ»ĪÆĪµĻ ĻĪæĻ ĻĻĪ±Ī³Ī¼Ī±ĻĪæĻĪæĪ¹ĪæĻĪ½ĻĪ±Ī¹ ĪĻĻ ĻĪ¹Ļ 12:00 Ī¹ĻĻĻĪæĻ Ī½ ĪæĪ¹ ĻĪ±ĻĪ±ĪŗĪ¬ĻĻ ĻĻĻĪ½ĪæĪ¹ ĻĪ±ĻĪ¬Ī“ĪæĻĪ·Ļ:
- 3 ĪĻĻ 6 ĪµĻĪ³Ī¬ĻĪ¹Ī¼ĪµĻ Ī·Ī¼ĪĻĪµĻ (ĪĻĻĪ¹ĪŗĪ®, ĪĪµĻĻĪ±Ī»ĪæĪ½ĪÆĪŗĪ·, Ī¼ĪµĪ³Ī¬Ī»Ī± Ī±ĻĻĪ¹ĪŗĪ¬ ĪŗĪĪ½ĻĻĪ±).
- 5 ĪĻĻ 7 ĪµĻĪ³Ī¬ĻĪ¹Ī¼ĪµĻ Ī·Ī¼ĪĻĪµĻ (Ļ ĻĻĪ»ĪæĪ¹ĻĪ· ĪĪ»Ī»Ī¬Ī“Ī±).
ĪĻĪæĻĪµĪÆĻ Ī½Ī± ĪŗĪ¬Ī½ĪµĪ¹Ļ ĻĪ·Ī½ ĪµĻĪ¹ĻĻĻĪæĻĪ® ĻĪæĻ
ĪĪ©Ī”ĪĪĪ Ī¼ĪĻĪ± ĻĪµĀ 20 Ī·Ī¼ĪĻĪµĻ Ī±ĻĻ ĻĪ·Ī½ Ī·Ī¼ĪµĻĪæĪ¼Ī·Ī½ĪÆĪ± ĻĪæĻ
ĻĪ±ĻĪĪ»Ī±Ī²ĪµĻ ĻĪ·Ī½ ĻĪ±ĻĪ±Ī³Ī³ĪµĪ»ĪÆĪ± ĻĪæĻ
ĪŗĪ±Ī¹ ĪµĻĻĻĪæĪ½ ĻĪæ ĻĻĪæĻĻĪ½ ĻĪ»Ī·ĻĪæĪÆ ĻĪ¹Ļ ĻĻĪæĻĻĪæĪøĪĻĪµĪ¹Ļ ĪµĻĪ¹ĻĻĻĪæĻĪ®Ļ (Ī“ĪµĪ½ ĪµĪÆĪ½Ī±Ī¹ ĪŗĪ±ĻĪµĻĻĻĪ±Ī¼Ī¼ĪĪ½Īæ, Ī±Ī½ĪæĪ¹Ī³Ī¼ĪĪ½Īæ ĪŗĪ»Ļ). ĪĪ¬ĪøĪµ ĻĪµĻĪ¹ĻĻĻĻĪµĻĪ± Ī³Ī¹Ī± ĻĪ· Ī“Ī¹Ī±Ī“Ī¹ĪŗĪ±ĻĪÆĪ± Ī±ĻĻ ĻĪæ Ī¤Ī¼Ī®Ī¼Ī± ĪĪ¾Ļ
ĻĪ·ĻĪĻĪ·ĻĪ·Ļ Ī ĪµĪ»Ī±ĻĻĪ½ ĻĻĪæ 211 188 30 12, Ī±ĻĻ ĪĪµĻ
ĻĪĻĪ± ĪĻĻ ĪŗĪ±Ī¹ Ī£Ī¬Ī²Ī²Ī±ĻĪæ 8 Ļ.Ī¼. ā 10 Ī¼.Ī¼. Ī®Ā ĪµĪ“Ļ.